Larson Financial Group LLC Invitae Corp Transaction History

Larson Financial Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$0.6 - $1.53 $466 - $1,188	777 Added 712.84%	886 $0
Q2 2021 Aug 10, 2021	SELL	$26.09 - $40.4 $5,035 - $7,797	-193 Reduced 63.91%	109 $4,000
Q4 2020 Jan 14, 2021	BUY	$39.09 - $57.4 $1,954 - $2,870	50 Added 19.84%	302 $13,000
Q3 2020 Oct 08, 2020	BUY	$28.43 - $44.67 $1,990 - $3,126	70 Added 38.46%	252 $11,000
Q2 2020 Jul 10, 2020	BUY	$11.71 - $30.29 $2,131 - $5,512	182 New	182 $6,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Larson Financial Group LLC with notifications on news.